In addition, targeting the serine/threonine protein kinase, glycogen synthase kinase 3β (GSK-3β), is an important clue in several signaling pathways, such as cell proliferation, apoptosis, inflammation, and glycogen metabolism, which are involved in treatment of AD, Parkinson’s disease and type 2 diabetes mellitus [110]. Here, GSK3B is linked to Alzheimer disease.